Safety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults ≥65 Years of Age

Completed · Phase 3

Conditions studied: Pneumococcal Disease

In brief

Study of the safety and immunogenicity of 20vPnC and influenza vaccine administered at the same visit or separately

Key facts

Study ID

NCT04526574

Run by

Pfizer

People needed

1796

Starts

2020-09-01

Expected to finish

2021-06-29

Last updated by the study team

2022-07-08

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or female participants ≥65 years of age at the time of consent
• Adults determined by clinical assessment, including medical history and clinical judgment, to be eligible for the study, including adults with preexisting stable disease
• Adults who have no history of ever receiving a pneumococcal vaccine, or have a history of receiving a licensed pneumococcal vaccination ≥6 months prior to first study vaccination.

You may not qualify if…

• History of severe adverse reaction associated with a vaccine and/or severe allergic reaction (eg, anaphylaxis)
• Previous vaccination with any investigational pneumococcal vaccine, or planned receipt of any licensed or investigational pneumococcal vaccine through study participation.
• Vaccination with any influenza or pneumococcal vaccine <6 months before investigational product administration, or planned receipt of any licensed or investigational non-study influenza vaccine during study participation.
• - Serious chronic disorder, that in the investigator's opinion would make the participant inappropriate for entry into the study
• Other acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or investigational product administration or may interfere with the interpretation of study results

Where it is running

• East Valley Gastroenterology and Hepatology Associates — Chandler, Arizona, United States
• Hope Research Institute — Phoenix, Arizona, United States
• Paradigm Clinical Research Center — Redding, California, United States
• Artemis Institute for Clinical Research — San Diego, California, United States
• California Research Foundation — San Diego, California, United States
• Diablo Clinical Research, Inc. — Walnut Creek, California, United States
• Alliance for Multispecialty Research, LLC - Miami — Coral Gables, Florida, United States
• Nature Coast Clinical Research — Crystal River, Florida, United States
• Indago Research and Health Center, Inc. — Hialeah, Florida, United States
• Jacksonville Center for Clinical Research — Jacksonville, Florida, United States
• Suncoast Research Group, LLC — Miami, Florida, United States
• Alpha Science Research, LLC — Miami, Florida, United States
• Lakes Research — Miami Lakes, Florida, United States
• Clinical Neuroscience Solutions, Inc — Orlando, Florida, United States
• Meridian Clinical Research, LLC — Savannah, Georgia, United States
• Clinical Research Atlanta — Stockbridge, Georgia, United States
• Advanced Clinical Research — Meridian, Idaho, United States
• Alliance for Multispecialty Research, LLC — El Dorado, Kansas, United States
• Alliance for Multispecialty Research, LLC — Wichita, Kansas, United States
• Alliance for Multispecialty Research, LLC — Wichita, Kansas, United States
• Alliance for Multispecialty Research, LLC — New Orleans, Louisiana, United States
• Centennial Medical Group — Elkridge, Maryland, United States
• Meridian Clinical Research, LLC — Rockville, Maryland, United States
• Sundance Clinical Research, LLC — St Louis, Missouri, United States
• Alliance for Multispecialty Research, LLC — Mobile, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.